SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Trump For President

The Trump Crypto coin is trending as the community discusses its volatile price action and potential connection to political events, as well as possible connections to the Trump family. Community members are actively debating its long-term potential amidst broader discussions about memecoins and the crypto market. Some traders are expressing concerns over recent performance.

Shibmas was launched on the 9th Of December. The project is a meme token and gives homage to Shiba Inu the token. The token is a playful character who is bringing the Christmas spirit to token holders all around the world. We plan on getting many listings on various exchanges in the coming days. We have over 1000 holders in 24 hours and we aim on getting over 10000 holders within the next week and in the run up to Christmas

Shibmas

Shibmas ($SMAS) is gaining attention, with community members noting its trending status and "moon vibes." Talk centers on its availability on Phantom Wallet and potential breakout, as well as its connection to the Shiba Inu ($SHIB) community. Traders are closely watching price action and volume for signals.

WorldFinancial

$WLFI is trending amidst community discussions around its association with $TRUMP and potential for 'generational wealth.' Some speculate on its regulatory compliance benefits and tokenization of real-world assets, while others express skepticism, citing centralization and lack of utility; the community is split between bullish excitement and bearish concern.

Avidity Biosciences, Inc. engages in the development of a new class of oligonucleotide-based therapies called Antibody Oligonucleotide Conjugates (AOC). It utilizes its AOC platform to design, engineer, and develop therapeutics that combine the tissue selectivity of monoclonal antibodies and the precision of oligonucleotide-based therapies in order to access previously undruggable tissue and cell types and more effectively target underlying genetic drivers of diseases. The company was founded by Troy E. Wilson, Kent Hawryluk, Mark E. Davis, and Francis Patrick McCormick on November 13, 2012 and is headquartered in San Diego, CA.

Avidity Biosciences Inc

Avidity Biosciences ($RNA) is trending amid rumors of a potential acquisition by Novartis, which has sparked significant discussion among investors. The community is focused on the potential buyout price and what this may mean for other companies in the RNA therapeutics space. Community members point to strong financials and potential for continued growth and have fueled speculation around other potential suitors.

Just a dead guy

$DEADGUY is trending as the community promotes the coin and shares the contract address. Social media mentions are up as the coin gains holders and climbs in wallet rankings. Discussion includes speculation that $DEADGUY could surpass other similar coins.

Columbus Circle Capital Corp. I operates as a blank check company. It was formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, which refer to throughout this prospectus as initial business combination. The company was founded in June 2024 and is headquartered in New York, NY.

Columbus Circle Capital Corp I - Ordinary Shares - Class A

Columbus Circle Capital Corp I ($BRR) is trending as the community discusses recent board member additions, including Eric Jackson, with speculation that Mike Alfred may join soon. Chatter suggests a potential short-term swing due to low risk near the NAV floor and excitement around cheap options. Some are comparing the potential of $BRR options to past option surges.

AlienBase

AlienBase ($ALB) is trending as chatter increases around its potential Coinbase listing and a recent video highlighting the token. Community members are actively discussing the token's low market cap compared to competitors and speculating on future price appreciation. The project is also getting noticed for its working product and the belief that it will outperform other base coins.

Klarna Group Plc operates as an investment holding company. It provides an e-commerce payment solutions for merchants and shoppers. The firm connect an array of different financial services and commerce organizations, from PSPs, traditional banks, card networks and open banking providers, to commerce enablers, technology partners, in-store payments providers and shipping and return logistics providers. The company was founded by Gustav Erik Niklas Adalberth, Karl Anders Victor Jacobsson, and Sebastian Marcin Siemiatkowski in 2005 and is headquartered in London, the United Kingdom.

Klarna Group plc

Klarna is trending as the community discusses its potential for growth and market dominance in the Buy Now, Pay Later sector, especially with its AI integrations and expansion in the U.S. Some are comparing its CEO to Elon Musk, highlighting the company's early partnership with OpenAI as a key advantage. Despite a recent IPO and some volatility, many see long-term potential and undervalued status, with some anticipating a short squeeze.

Sagimet Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel therapeutics for the treatment of infectious diseases. Its lead drug candidate, denifanstat, is an oral, once-daily pill and selective fatty acid synthase (FASN) inhibitor in development for the treatment of nonalcoholic steatohepatitis (NASH). The company was founded by Urs F. Greber, Ari Helenius, and Lucas Pelkmans on December 19, 2006 and is headquartered in San Mateo, CA.

Sagimet Biosciences Inc - Ordinary Shares - Series A

Sagimet Biosciences Inc

Sagimet Biosciences ($SGMT) is trending due to positive Phase 3 trial data for its acne treatment, denifanstat, potentially offering a new Accutane alternative with fewer side effects. The community is buzzing about its market potential, especially in China, and speculating about a possible buyout from larger skincare companies. Some analysts see the stock as undervalued, citing its market cap and opportunities in both the acne and MASH markets.

DIA is a trustless oracle network delivering unmatched data coverage and fully verifiable feeds to power dApps on any blockchain, powered by the $DIA utility token.  By sourcing data directly from 100+ primary sources, DIA ensures unparalleled accuracy and breadth of coverage, enabling protocols to support any asset with confidence. Its modular, rollup-based architecture executes all oracle operations onchain, guaranteeing full verifiability and eliminating reliance on opaque third parties.  The network is fully permissionless, allowing anyone to deploy oracles, operate nodes, and stake to secure the data pipeline. This makes DIA the most transparent and trustless oracle solution available.  Today, DIA supports 20,000+ assets across 60+ blockchains and powers 200+ dApps spanning DeFi, RWA tokenization, gaming, and more, scaling the oracle infrastructure that Web3 can verify, not just trust.

DIA is trending as the community discusses its potential as a competitor to Chainlink, focusing on its smaller market cap and recent news. Some traders are pointing to technical indicators suggesting a possible breakout, while others caution about potential traps and volatility. The increase in watchers and sustained chatter on platforms like Twitch may also be contributing to the increased interest.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Calamos Investments Closed-End Funds (NASDAQ: CHI, CHY, CSQ, CGO, CHW, CCD and CPZ) Announce Monthly Distributions and Required Notifications of Sources of Distribution

Calamos Investments Closed-End Funds (NASDAQ: CHI, CHY, CSQ, CGO, CHW, CCD and CPZ) Announce Monthly Distributions and Required Notifications of Sources of Distribution Calamos Investments Closed-End...

CORRECTION: Calamos Investments Closed-End Funds (NASDAQ: CHI, CHY, CSQ, CGO, CHW, CCD and CPZ) Announce Monthly Distributions and Required Notifications of Sources of Distribution

CORRECTION: Calamos Investments Closed-End Funds (NASDAQ: CHI, CHY, CSQ, CGO, CHW, CCD and CPZ) Announce Monthly Distributions and Required Notifications of Sources of Distribution CORRECTION...

Calamos Strategic Total Return Fund to Issue Monthly Dividend of $0.10 (NASDAQ:CSQ)

Calamos Strategic Total Return Fund (NASDAQ:CSQ - Get Free Report) declared a monthly dividend on Monday, April 1st, Zacks reports. Shareholders of record on Friday, April 12th will be given a...

Calamos Strategic Total Return Fund operates as a Closed-End Investment Fund/Investment Trust. The Fund seeks total return through a combination of capital appreciation and current income by investing in a diversified portfolio of equities, convertible securities and high yield corporate bonds. Its investment services are provided through Calamos Advisors LLC. The company was founded on December 31, 2003 and is headquartered in Naperville, IL.

Calamos Strategic Total Return Fund

Cut 25 bps

Cut 50+ bps

No change

What will the Fed decide at its October meeting? Polymarket gives a 92% chance of a 25 bps cut. 
 
*Powered by Polymarket

Current Price	$19.07
Prev Close	$18.92
Open	$19.02
Dividend Yield	7.10%
50-Day Moving Average	$18.95
Beta	1.01
Avg. Volume	201,586.29
PE Ratio	10.99

52-Week High	$19.57
52-Week Low	$13.11
Market Capitalization	$3.06B
EPS (Annual)	$5.37
Price to Book	1.16
Revenue Per Employee	N/A
Enterprise Value/EBITDA	N/A

CSQ
Calamos Strategic Total Return Fund

Feed

News

Sentiment

Fundamentals

Info

Latest CSQ News

CSQCalamos Strategic Total Return Fund